Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis.

Gala M Godoy BrewerGeorge SalemMuhammad A AfzalBerkeley N LimketkaiZadid HaqMaryam TajamalJoanna MeliaMark LazarevFlorin M SelaruAlyssa M Parian

Published in: BMJ open gastroenterology (2022)

Ustekinumab presents a safe and effective therapy for treatment of pCD. Prospective, randomised trials are needed to further elucidate long-term efficacy of ustekinumab for pCD.

Keyphrases

clinical trial
open label
study protocol
randomized controlled trial
combination therapy
placebo controlled